The Ohio Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legally binding contract that establishes the terms and conditions under which Gentling, Inc. can utilize certain technologies or intellectual property developed or owned by The University of North Texas Health Science Center for commercial purposes. This agreement ensures that both parties are protected and that the rights, obligations, and responsibilities of each party are clearly defined. This particular Ohio Collateral License Agreement sets forth the terms applicable to Gentling, Inc. and The University of North Texas Health Science Center specifically. It outlines the specific technologies, inventions, or intellectual property rights that are subject to licensing and the scope of rights granted to Gentling, Inc. by The University of North Texas Health Science Center. The licensee, Gentling, Inc., has the right to use, develop, sell, or sublicense the licensed technologies or intellectual property within the agreed upon field of use. The Ohio Collateral License Agreement also includes provisions related to financial considerations, including upfront fees, milestone payments, royalties, and distribution of revenues generated from the licensed technologies or intellectual property. Additionally, it may specify the duration of the license and any termination clauses that both parties must adhere to. It is important to note that different types of Ohio Collateral License Agreements may exist between Gentling, Inc. and The University of North Texas Health Science Center, depending on the specific technologies or intellectual property being licensed. For instance, there may be separate agreements for software licensing, patent licensing, or specific types of research collaborations between the two entities. Overall, the Ohio Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center serves as a crucial legal document that protects the respective rights and interests of both parties, enables commercialization of innovative technologies, and facilitates the advancement of knowledge and progress in the scientific and medical field.